S. G. Deshpande, T. Pathak / Tetrahedron Letters 45 (2004) 2255–2258
2257
In order to establish the usefulness of these new hexo-
OR
O
i)
O
O
pyranosyl nucleosides, 8 was subjected to nucleophilic
displacement. Problems associated with any loss of
acetyl groups were circumvented by reacetylating the
product mixture. Thus, a DMF solution of 8 was treated
with NaOAc at 150 ꢁC for 20 h and the resulting mixture
of products was acetylated. A typical work-up and
Ph
T
10
ii)
N
O
25 R = H
purification yielded 1-(2,3,4,6-tetra-O-acetyl-b-D-allo-
26 R = PNBz
pyranosyl) thymine 20 in 70% yield. Although the syn-
thesis of allopyranosyl thymine had been reported
earlier,8a the present work is the first report on the
conversion of a versatile intermediate such as 8 into an
allopyranosyl nucleoside. Since this route to allopyr-
anosyl thymine derivatives is expected to be general in
nature, treatment of compound 8 with LiN3 in DMF at
120 ꢁC for 20 h followed by reacetylation gave 1-(2,4,6-
Scheme 4. Reagents and conditions: (i) morpholine, DMSO, 90 ꢁC,
25 h, 80%; (ii) p-NO2C6H4COCl, py, rt, 5 h, 80%.
of the mannoepoxide 10 would not have been possible
without the formation of 9. The usefulness of the epoxy
nucleoside 10 has been exemplified by synthesizing a
new deoxyaminonucleoside 25. Moreover, the easy
availability of 24 and 25 would enable us to broaden the
scope of our studies on aminonucleosides1 and vinyl
sulfone-modified nucleosides.15 Research is currently in
progress to study the widest possible application of these
intermediates for the synthesis of an array of new
hexopyranosyl nucleosides.16
tri-O-acetyl-3-azido-3-deoxy-b-
D
-allopyranosyl)
thy-
mine 21 in 61% yield. Compound 21 is the first of its
kind to be reported. Similarly, treatment of 8 with
Na(p)STol in DMF at 90 ꢁC, followed by acetylation
afforded
1-(2,4,6-tri-O-acetyl-3-deoxy-3-S-tolyl-b-D-
allopyranosyl) thymine 22 in 70% yield. In a different set
of experiments the mixture of products obtained from
the reaction of 8 with the sodium salt of p-tolylthiol, was
deacetylated using NaOMe in methanol to give 23. A
DMF solution of 23 was benzylidenated using a stan-
dard procedure to afford 24 in 65% overall yield in three
steps (Scheme 3). The 20,30-O-anhydro hexopyranosyl
thymine 10 was also subjected to nucleophilic ring
opening reactions. Thus, a DMSO solution of 10 was
treated with morpholine at 90 ꢁC for 25 h. A single
compound, the 30-deoxy-30-N-morpholino-altropyrano-
syl nucleoside 25 was obtained in 80% yield, which was
identified as its p-nitrobenzoyl derivative 26 (Scheme 4).
Acknowledgements
T.P. thanks the DST, New Delhi, India for financial
support. S.G.D. thanks CSIR, New Delhi, India for a
fellowship. Both the authors thank Dr. M. S. Shashi-
dhar for his support and interest in this work.
In conclusion, we have devised a methodology for the
synthesis of a strategically tosylated hexopyranosyl
nucleoside 8, which can be easily transformed into sev-
eral allopyranosyl nucleosides. Moreover, 8 can be
transformed into two other extremely important key
synthons 9 and 10. It should be noted that the synthesis
References and notes
1. Pathak, T. Chem. Rev. 2002, 102, 1623–1667, and refer-
ences cited therein.
2. Fischer, E.; Helferich, B. Ber. 1914, 47, 210–235.
3. (a) Zorbach, W.; Durr, G. J., Jr. J. Org. Chem. 1962, 27,
1474–1477; (b) Langen, P.; Etzold, G. Biochem. Z. 1963,
339, 190–197.
4. Lerner, L. M.; Kohn, P. J. Med. Chem. 1964, 7, 655–658.
5. Nord, L. D.; Dalley, N. K.; McKernan, P. A.; Robins,
R. K. J. Med. Chem. 1987, 30, 1044–1054.
RO
O
i) or, ii) or, iii)
RO
T
8
6. Knapp, S. Chem. Rev. 1995, 95, 1859–1876.
7. (a) Ostrowski, T.; Wroblowski, B.; Busson, R.; Rozenski,
J.; De Clercq, E.; Bennett, M. S.; Champness, J. N.;
Summers, W. C.; Sanderson, M. R.; Herdewijn, P. J. Med.
Chem. 1998, 41, 4343–4353; (b) Wouters, J.; Herdewijn, P.
Bioorg. Med. Chem. Lett. 1999, 9, 1563–1566.
OR
X
20 R = Ac; X = OAc
21 R = Ac; X = N3
22 R = Ac; X = STol(p)
23 R = H; X = STol(p)
8. (a) Augustyns, K.; Rozenski, J.; Van Aerschot, A.;
Janssen, G.; Herdewijn, P. J. Org. Chem. 1993, 58,
2977–2982; (b) Bjoersne, M.; Classon, B.; Kvarnstroem,
I.; Samuelsson, B. Tetrahedron 1993, 49, 8637–8644; (c)
Hanessian, S.; Conde, J. J.; Khai, H. H.; Lou, B.
Tetrahedron 1996, 52, 10827–10834; (d) Sugimura, H.;
Sujino, K. Nucleos. Nucleot. 1998, 17, 53–63.
O
O
O
T
iv)
Ph
OH
STol(p)
24
Scheme 3. Reagents and conditions: (i) a. NaOAc, DMF, 150 ꢁC, 20 h;
b. Ac2O, py, rt, overnight, 70%; (ii) a. LiN3, DMF, 120 ꢁC, 20 h; b.
Ac2O, py, rt, overnight, 61%; (iii) a. p-TolSH, NaOMe, DMF, 90 ꢁC,
10 h; b. Ac2O, py, rt, overnight, 70%; (iv) a. p-TolSH, NaOMe, DMF,
90 ꢁC, 10 h; b. NaOMe, MeOH, rt, 6 h; c. PhCH(OCH3)2, TsOH,
DMF, 100 ꢁC, 1.5 h, 65% (in three steps).
9. Moffatt, J. G. Nucleoside Analogs: Chem., Biol., Med.
Appl.; NATO Adv. Study Inst. Ser., Ser. A 1979, A26, 71–
165.
10. A Ômonotosyl monoacetateÕ hexopyranosyl nucleoside is
known, see: Stevens, C. L.; Nielsen, N. A.; Blumbergs, P.
J. Am. Chem. Soc. 1964, 86, 1894–1895.